In-hospital outcomes among amyloidosis patients with atrial fibrillation: A propensity score-matched analysis

IF 2.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Arrhythmia Pub Date : 2024-06-18 DOI:10.1002/joa3.13100

Yong-Hao Yeo MBBS, Boon-Jian San MBBS, Qi-Xuan Ang MBBS, Min-Choon Tan MD, Jian Liang Tan MD

{"title":"In-hospital outcomes among amyloidosis patients with atrial fibrillation: A propensity score-matched analysis","authors":"Yong-Hao Yeo MBBS, Boon-Jian San MBBS, Qi-Xuan Ang MBBS, Min-Choon Tan MD, Jian Liang Tan MD","doi":"10.1002/joa3.13100","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The impact of atrial fibrillation (AF) among patients with amyloidosis on in-hospital outcomes is not well-established. We aimed to examine in-hospital outcomes among patients admitted with a primary diagnosis of AF with and without amyloidosis.</p>\n </section>\n \n <section>\n \n <h3> Methods and Results</h3>\n \n <p>We queried the Nationwide Readmissions Database to compare the in-hospital outcomes among AF patients with and without amyloidosis. Our study demonstrated that in-hospital all-cause mortality, adverse events, and 30-day readmission were comparable between the two groups.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Patients with AF and concurrent amyloidosis did not have worse in-hospital outcomes than those with AF alone.</p>\n </section>\n </div>","PeriodicalId":15174,"journal":{"name":"Journal of Arrhythmia","volume":"40 4","pages":"1001-1004"},"PeriodicalIF":2.2000,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11317666/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arrhythmia","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/joa3.13100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The impact of atrial fibrillation (AF) among patients with amyloidosis on in-hospital outcomes is not well-established. We aimed to examine in-hospital outcomes among patients admitted with a primary diagnosis of AF with and without amyloidosis.

Methods and Results

We queried the Nationwide Readmissions Database to compare the in-hospital outcomes among AF patients with and without amyloidosis. Our study demonstrated that in-hospital all-cause mortality, adverse events, and 30-day readmission were comparable between the two groups.

Conclusions

Patients with AF and concurrent amyloidosis did not have worse in-hospital outcomes than those with AF alone.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

伴有心房颤动的淀粉样变性患者的院内预后：倾向评分匹配分析

背景：淀粉样变性患者心房颤动（房颤）对院内预后的影响尚未得到充分证实。我们旨在研究初诊为心房颤动并伴有和不伴有淀粉样变性的入院患者的院内预后：我们查询了全国再入院数据库，比较了有淀粉样变性和无淀粉样变性心房颤动患者的院内预后。我们的研究表明，两组患者的院内全因死亡率、不良事件和30天再入院率相当：结论：房颤并发淀粉样变性患者的院内预后并不比单纯房颤患者差。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊